T. Peter Kingham, MD, FACS

T. Peter Kingham, MD, FACS

T. Peter Kingham, MD, FACS

Profile:

Dr. Kingham is an Associate Attending Surgeon in the Hepatopancreatobiliary Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center. Dr. Kingham directs exciting clinical trials examining methods for quickly determining the stage of pancreatic cancer, identifying genetic signatures of colorectal cancer to create genetic scoring systems, and using an image-guided 3-dimensional liver modeling system to improve outcomes of liver surgery. He has also written multiple book chapters and many papers on topics related to treating tumors of the liver, bile ducts, gallbladder, and pancreas, and given lectures internationally.

Dr. Kingham is also the Director of Global Cancer Disparity Initiatives at MSK. Over the past 15 years, he has spent time in developing countries — Tanzania, Sierra Leone, South Africa, Mexico, Malawi, and Nigeria — providing surgery and cancer care, and also training local medical professionals. These experiences led him, in 2007, to co-found Surgeons OverSeas (SOS), a non-profit organization for which he now serves as president. In 2015, he was appointed Director of Global Cancer Disparity Initiatives at MSK where he has created a consortium of hospitals in West Africa that allows MSK physicians to collaborate with physicians working in low-income countries. These efforts have led to several prospective studies that will determine how to diagnose patients with cancer in low resource environments and determine why some cancers seem to behave differently in West African patients when compared with the same cancers in US patients.


Meet Dr. Kingham:


Publications:

  1. Buisman, FE, Galjart, B, van der Stok, EP, Balachandran, VP, Boerner, T, Drebin, JA et al.. Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy. World J Surg. 2019; :. doi: 10.1007/s00268-019-05121-9. PubMed PMID:31410513 .
  2. Knapp, GC, Sharma, A, Olopade, B, Alatise, OI, Olasehinde, O, Arije, OO et al.. An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria. World J Surg. 2019; :. doi: 10.1007/s00268-019-05100-0. PubMed PMID:31407091 .
  3. Attiyeh, MA, Chakraborty, J, McIntyre, CA, Kappagantula, R, Chou, Y, Askan, G et al.. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2019;44 (9):3148-3157. doi: 10.1007/s00261-019-02112-1. PubMed PMID:31243486 PubMed Central PMC6692205.
  4. McIntyre, CA, Pulvirenti, A, Lawrence, SA, Seier, K, Gonen, M, Balachandran, VP et al.. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 2019;48 (6):832-836. doi: 10.1097/MPA.0000000000001342. PubMed PMID:31210665 .
  5. Knapp, GC, Alatise, OI, Olasehinde, OO, Adeyeye, A, Ayandipo, OO, Weiser, MR et al.. Is Colorectal Cancer Screening Appropriate in Nigeria?. J Glob Oncol. 2019;5 :1-10. doi: 10.1200/JGO.19.00035. PubMed PMID:31170018 PubMed Central PMC6613663.
  6. Deng, L, Ismond, K, Liu, Z, Constable, J, Wang, H, Alatise, OI et al.. Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study. Cancer Epidemiol. Biomarkers Prev. 2019;28 (8):1283-1291. doi: 10.1158/1055-9965.EPI-18-1291. PubMed PMID:31151939 PubMed Central PMC6677589.
  7. Olasehinde, O, Arije, O, Wuraola, FO, Samson, M, Olajide, O, Alabi, T et al.. Life Without a Breast: Exploring the Experiences of Young Nigerian Women After Mastectomy for Breast Cancer. J Glob Oncol. 2019;5 :1-6. doi: 10.1200/JGO.18.00248. PubMed PMID:31095453 PubMed Central PMC6550027.
  8. Creasy, JM, Goldman, DA, Gonen, M, Dudeja, V, O'Reilly, EM, Abou-Alfa, GK et al.. Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.03.370. PubMed PMID:31027875 .
  9. Narayan, RR, Kingham, TP. ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases. Ann. Surg. Oncol. 2019; :. doi: 10.1245/s10434-019-07360-5. PubMed PMID:30989499 .
  10. Buisman, FE, Homs, MYV, Grünhagen, DJ, Filipe, WF, Bennink, RJ, Besselink, MGH et al.. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial. BMC Cancer. 2019;19 (1):327. doi: 10.1186/s12885-019-5515-6. PubMed PMID:30953467 PubMed Central PMC6451273.
  11. Gholami, S, Kemeny, NE, Boucher, TM, Gönen, M, Cercek, A, Kingham, TP et al.. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. Ann. Surg. 2019; :. doi: 10.1097/SLA.0000000000003248. PubMed PMID:30817353 .
  12. Narayan, RR, Goldman, DA, Gonen, M, Reichel, J, Huberman, KH, Raj, S et al.. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. Ann. Surg. Oncol. 2019;26 (6):1824-1832. doi: 10.1245/s10434-019-07201-5. PubMed PMID:30706231 PubMed Central PMC6511310.
  13. Pak, LM, Gagnière, J, Allen, PJ, Balachandran, VP, D'Angelica, MI, DeMatteo, RP et al.. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases. J. Gastrointest. Surg. 2019;23 (4):760-767. doi: 10.1007/s11605-019-04106-2. PubMed PMID:30680630 .
  14. Lawrence, SA, McIntyre, CA, Pulvirenti, A, Seier, K, Chou, Y, Gonen, M et al.. Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. J. Am. Coll. Surg. 2019;228 (4):595-601. doi: 10.1016/j.jamcollsurg.2018.12.018. PubMed PMID:30630087 .
  15. Olasehinde, O, Alatise, OI, Arowolo, OA, Mango, VL, Olajide, OS, Omisore, AD et al.. Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities. Eur J Cancer Care (Engl). 2019;28 (2):e12986. doi: 10.1111/ecc.12986. PubMed PMID:30614109 PubMed Central PMC6430195.
  16. Narayan, RR, Creasy, JM, Goldman, DA, Gönen, M, Kandoth, C, Kundra, R et al.. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations. Cancer. 2019;125 (4):575-585. doi: 10.1002/cncr.31850. PubMed PMID:30427539 PubMed Central PMC6636637.
  17. Cohen, NA, Kingham, TP. Minimally Invasive Staging Surgery for Cancer. Surg. Oncol. Clin. N. Am. 2019;28 (1):61-77. doi: 10.1016/j.soc.2018.07.006. PubMed PMID:30414682 .
  18. Kunstman, JW, Goldman, DA, Gönen, M, Balachandran, VP, D'Angelica, MI, Kingham, TP et al.. Outcomes after Pancreatectomy with Routine Pasireotide Use. J. Am. Coll. Surg. 2019;228 (2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. PubMed PMID:30414453 .
  19. Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP et al.. Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients. World J Surg. 2019;43 (2):395. doi: 10.1007/s00268-018-4845-x. PubMed PMID:30406321 .
  20. Harding, JJ, Nandakumar, S, Armenia, J, Khalil, DN, Albano, M, Ly, M et al.. Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies. Clin. Cancer Res. 2019;25 (7):2116-2126. doi: 10.1158/1078-0432.CCR-18-2293. PubMed PMID:30373752 PubMed Central PMC6689131.
Search PubMed